Insys Therapeutics Bankruptcy: INSY Stock Soars on Latest News
Insys Therapeutics bankruptcy news for Wednesday has INSY stock heading higher.Source: Insys TherapeuticsInsys Therapeutics (NASDAQ:INSY) notes that it now has approval from the U.S. Bankruptcy Court for...
Zynerba Up on Second Patent for Cannabidiol Candidate in 2019
Zynerba (ZYNE) gets a new U.S. patent covering methods of treating autism spectrum disorder with cannabidiol, a key compound of its lead pipeline candidate, Zygel.
Biotech Stock Roundup: Celgene Submits MS Drug to FDA, INSY & CBAY Crash
Key highlights of the past week include regulatory approvals, collaborations and pipeline updates.
Insys Therapeutics' stock jumps after bankruptcy court approves 'First Day' motions
Shares of Insys Therapeutics Inc. shot up 83% in premarket trade Wednesday, after the bankrupt opioid maker said it received interim court approvals for its "First Day" motions related to bankruptcy...
INSYS Therapeutics, Inc. Receives Court Approval of “First Day” Motions
INSYS Therapeutics, Inc. (INSY) (“INSYS” or the “Company”), a specialty pharmaceutical development and distribution company, announced that on June 11, 2019 INSYS received interim approvals from the U.S....
Insys Down on Bankruptcy News Amid Increasing Legal Expenses
Insys (INSY) crashes as it files for bankruptcy protection amid rising legal settlement dues.
Stoke Therapeutics Files Proposed Terms For IPO
Quick Take Stoke Therapeutics ( STOK ) has filed to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement . The firm is developing therapeutics for severe...
Investors are pinning hopes on this asset again — but beware, says Saxo Bank
Our call of the day, from Saxo Bank’s head of commodity strategy Ole Hansen, cautions investors against getting too excited over this haven asset again too soon.
Chandler opioid maker files for bankruptcy protection
Costs related to recent federal settlements and other lawsuits have forced the Valley drugmaker to file for bankruptcy protection.
Top Trending: Insys files for bankruptcy, Hudson's Bay offers to go private and more
Yahoo Finance's Adam Shapiro fills you in on the top trending news stories that you need to know.
The culture of compliance efforts at INSYS is the promotion of ethical behavior by employees and corporate responsibility by the company.
In accordance with our values, the INSYS compliance function supports the development and implementation of practices to facilitate compliance with applicable laws and corporate policy. As importantly, due diligence in preventing and detecting misconduct or non-compliance with laws or regulations is supported by these effective compliance systems.
Our employees are encouraged to report concerns or suspected cases of misconduct without the fear of retaliation. Employees can do this through line managers or through our confidential Compliance Helpline reporting channels. All concerns and allegations are fairly and independently investigated, and disciplinary action, if applicable, is commensurate with the issues presented.
The INSYS Compliance Helpline enables employees to report a concern or receive information or advice anonymously. The Compliance Helpline can be reached by phone or online via the web–reporting tool. Accessible 24 hours a day, 7 days a week, 365 days a year and offered in 70 languages, the Compliance Helpline is operated by specially trained third–party representatives.